Altered expression of p53 and p27 proteins, alone or combined, as a predictor of metastatic potential in early invasive carcinoma of colon and rectum - A comparative clinicopathologic and molecular analysis

Cancer Detection and Prevention

Volumn 24, Issue 4, 2000, Pages 343-355

  Hirano, K ^a   Minamoto, T ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Clinical management; Combined analysis; Metastasis; Risk factor; Therapeutic option

Indexed keywords

CDKN1B; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASES; ENZYME INHIBITOR; MICROTUBULE ASSOCIATED PROTEIN; MICROTUBULE ASSOCIATED PROTEINS; PROTEIN P53; TUMOR MARKER; TUMOR PROTEIN;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BIOSYNTHESIS; CANCER INVASION; CHI SQUARE DISTRIBUTION; COLORECTAL TUMOR; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; METABOLISM; METASTASIS; NONPARAMETRIC TEST; PATHOLOGY; PROGNOSIS; RISK FACTOR; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; COLORECTAL NEOPLASMS; CYCLIN-DEPENDENT KINASES; ENZYME INHIBITORS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMAN; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; PROGNOSIS; PROTEIN P53; RISK FACTORS; STATISTICS, NONPARAMETRIC; SUPPORT, NON-U.S. GOV'T; TUMOR MARKERS, BIOLOGICAL;

EID: 0033789783     PISSN: 0361090X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (81)

1. Early (microinvasive) colorectal carcinoma Pathology, diagnosis, surgical treatment
2. Colorectal adenomas containing invasive carcinomas, Pathologic assessment of lymph node metastatic potential
3. Early invasive colorectal carcinomas metastatic to the lymph node with attention to their nonpolypoid development
4. Endoscopic polypectomy. Inadequate treatment for invasive colorectal carcinoma
5. Early invasive carcinoma in colonic polyps. A review of the literature with emphasis on the assessment of the risk of metastasis
6. The risk of lymph node metastasis in colorectal polyps with invasive adenocarcinoma
7. Prognostic factors in colorectal carcinomas arising in adenomas: Implications for lesions removed by endoscopic polypectomy
8. Endoscopically removed malignant colorectal polyps: Clinicopathologic correlations
9. Superficial-type adenomas and adenocarcinomas of the colon and rectum: A comparative morphological study
10. Molecular genetic alterations as potential prognostic indicators in colorectal carcinoma
11. The promise of molecular oncology
12. A genetic model for colorectal tumorigenesis
13. Prognostic significance of p53 overexpression in gastric and colorectal carcinoma
14. Increased p53 protein content of colorectal tumors correlates with poor survival
15. Immunohistochemical study of p53 expression in microwave-fixed sections of colorectal carcinoma and adenoma
16. Survival and acquired genetic alterations in colorectal cancer
17. Immunohistochemical analysis of p53 in colorectal cancer regarding clinicopathological correlation and prognostic significance
18. Association of p53 mutations with short survival in colorectal cancer
19. Association of p53 gene and protein alterations with metastasis in colorectal cancer
20. Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia
21. Cancer cell cycles
22. Cloning of p27(KIP1), a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals
23. p27(Kip1), a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest
24. Cancer prognostics: Past, present and p27
25. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas
26. High level expression of p27(Kip1) and cyclin D1 in some human breast cancer cells: Inverse correlation between the expression of p27(Kip1) and degree of malignancy in human breast and colorectal cancers
27. Mutations of the p53 gene and accumulation of the p53 protein: Common steps found in the majority of human cancers
28. p53 Analysis in diagnostic pathology
29. The p53 tumor suppressor gene as a common cellular target in human carcinogenesis
30. 13.1 and absence of mutations in human tumors
31. Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/kip1 in human malignancies
32. Chromosomal mapping of the cdc2 family of protein kinases, cdk3, cdk6, PISSLRE, and PITALRE, and a cdk inhibitor, p27(Kip1), to regions involved in human cancer
33. Assignment of the human p27KipI gene to 12p13 and its analysis in leukemias
34. Management of patients with invasive carcinoma removed by colonoscopic polypectomy
35. Early colorectal carcinoma with special reference to its development de novo
36. Application of the p53 gene mutation pattern for differential diagnosis of primary versus metastatic lung carcinomas
37. Frequent and characteristic K-ras activation and absence of p53 protein accumulation in aberrant crypt loci of the colon
38. Expression of cell-cycle regulators p27(Kip1) and cyclin E, alone and in combination, correlate with survival in young breast cancer patients
39. Decreased levels of the cell-cycle inhibitor p27(Kip1) protein: Prognostic implications in primary breast cancer
40. Prognosis of node-positive colon cancer
41. Conditional survival estimates in 34,963 patients with invasive carcinoma of the colon
42. Prognostic factors in colorectal cancer. Literature review for clinical application
43. Long-term results of curative resection of minimally invasive colorectal cancer
44. Desmoplastic response in biopsy specimens of early colorectal carcinoma is predictive of deep submucosal invasion
45. Infrequent K-ras activation in superficial-type (flat) colorectal adenomas and adenocarcinomas
46. Lower incidence of K-ras codon 12 mutation in flat colorectal adenomas than in polypoid adenomas
47. The evolution of cancer of the colon and rectum
48. p53 Allele losses, mutations and expression in breast cancer and their relationship to clinicopathological parameters
49. Accumulation of p53 protein correlates with poor prognosis in human lung cancer
50. High prevalence of p53 protein overexpression in patients with esophageal cancer patients in Linxian, China and its relationship to progression and prognosis
51. p53 Expression and prognosis in gastric carcinoma
52. Expression of p53 protein in colorectal cancer and its relationship to short-term prognosis
53. Prognostic value of p53 overexpression and c-Ki-ras gene mutations in colorectal cancer
54. Relationship among p53, stage, and prognosis of large bowel cancer
55. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis
56. Structure and function of the p53 tumor suppressor gene: Clues for rational cancer therapeutic strategies
57. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1
58. Clinical applications of research on angiogenesis
59. The unique physiology of solid tumors: Opportunities (and problems) for cancer therapy
60. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27
61. Translational control of p27(Kip1) accumulation during the cell cycle
62. Reduced expression of cyclin-dependent kinase inhibitor p27(Kip1) is associated with advanced stage and invasiveness of gastric carcinomas
63. Loss of altered subcellular localization of p27 in Barrett's associated adenocarcinoma
64. p27(Kip1) in human lung cancers: Differential changes in small cell and non-small cell carcinomas
65. Loss of cyclin-dependent kinase inhibitor p27(Kip1) is a novel prognostic factor in localized human prostate adenocarcinoma
66. Association of p27 levels with recurrence and survival in patients with stage C prostate carcinoma
67. Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases
68. Cyclin E-CDK2 is a regulator of p27Kip1
69. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27
70. RhoA stimulates p27(Kip) degradation through its regulation of cyclin E/CDK2 activity
71. Down-regulation of p27(Kip1) by two mechanisms, ubiquitin-mediated degradation and proteolytic processing
72. Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation
73. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells
74. Reduced expression and altered subcellular localization of the cyclin-dependent kinase inhibitor p27(Kip1) in human colon cancer
75. Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein
76. Impact of the cyclin-dependent kinase inhibitor of p27 on resistance of tumor cells to anticancer agents
77. Minilaparotomy approach to tumors of the right colon
78. Colorectal cancer. Comparison of laparoscopic with open approaches
79. Prospective multicenter study of the quality of oncologic resections in patients undergoing laparoscopic colorectal surgery for cancer